fda semaglutide shortage resolved february 21 2025 Says Ozempic, Wegovy fda semaglutide shortage resolved feb

Molecules with large addressable markets attract large trial programmes, which generate large evidence bases, which earn broad regulatory coverage

Narula said people currently taking compound versions of GLP-1 medications should reach out now to their health care provider to ask for a prescription for the branded version of the medication

References Food and Drug Administration

Rapid-acting insulin stays active in your body for around 3-5 hours for most people

Temperature-induced degradation does not just reduce potency

Treatment selection considers disease severity, prognostic factors, comorbidities, and patient preferences